TP53 and hypoalphalipoproteinemia, primary, 1: Molecular docking in this study further showed that these bioactive compounds of FHD interact with hub targets (CCL2, IL-10, PTGS2, TNF, MAPK1, IL-6, CXCL8, TP53, and VEGFA) with best affinity < −5 kcal/mol.